Corrigendum to "Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells" [Biochem. Pharmacol. 227 (2024) 116445]
Biochem Pharmacol. 2024 Nov:229:116497.
doi: 10.1016/j.bcp.2024.116497.
Epub 2024 Aug 22.
1 Laboratory of Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological sciences, KU Leuven, 3000 Leuven, Belgium.
2 Adaptive Immunology, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium.
3 Section Systems Medicine of Metabolism and Signaling, Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen 9713 AV, The Netherlands.
4 VIB-KU Leuven Center for Brain & Disease Research, 3000 Leuven, Belgium; Electrophysiology Unit, VIB-KU Leuven Center for Brain & Disease Research, 3000 Leuven, Belgium.
5 KU Leuven Genomics Core, Department of Human Genetics, KU Leuven, 3000 Leuven, Belgium.
6 KU Leuven Flow and Mass Cytometry Facility, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium.
7 BioNotus GCV, 2845 Niel, Belgium.
8 Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, KU Leuven, Rega Institute, 3000 Leuven, Belgium.
9 VIB-KU Leuven Center for Brain & Disease Research, 3000 Leuven, Belgium; VIB Bio Imaging Core, 3000 Leuven, Belgium.
10 Laboratory of Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological sciences, KU Leuven, 3000 Leuven, Belgium; BioNotus GCV, 2845 Niel, Belgium. Electronic address: pieter.annaert@kuleuven.be.